Founder of OpenEvidence chatbot says two-thirds of US physicians use the ad-powered tool, prompting a debate about patient care

Excerpt from Financial Times. Original publication ↗

Source: Financial Times

At a glance

Topic
Business
Country
🇬🇧 GB
Publisher language
EN
Added to Allnira